TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Biomedica Norden AB
Closing information (x1000 DKK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
3,034
|
3,063
|
3,323 |
Financial expenses |
112
|
78
|
108 |
Earnings before taxes |
-33
|
-40
|
-12 |
EBITDA |
414
|
372
|
459 |
Total assets |
1,579
|
1,841
|
2,375 |
Current assets |
601
|
535
|
597 |
Current liabilities |
268
|
505
|
942 |
Equity capital |
230
|
261
|
328 |
- share capital |
67
![]() |
67
|
73 |
Employees (average) |
1
|
2
![]() |
2 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
14.6%
|
14.2%
|
13.8% |
Turnover per employee |
3,034
|
1,532
|
1,662 |
Profit as a percentage of turnover |
-1.1%
|
-1.3%
|
-0.4% |
Return on assets (ROA) |
5.0%
|
2.1%
|
4.0% |
Current ratio |
224.3%
|
105.9%
|
63.4% |
Return on equity (ROE) |
-14.3%
|
-15.3%
|
-3.7% |
Change turnover |
-44
|
9
|
444 |
Change turnover % |
-1%
|
0%
|
15% |
Chg. No. of employees |
-1
|
0
![]() |
0 |
Chg. No. of employees % |
-50%
|
0%
![]() |
0% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.